Protecting Effects of Gonadotropin-Releasing Hormone Agonist on Chemotherapy-Induced Ovarian Damage in Premenopausal Breast Cancer Patients: A Systematic Review and Meta-Analysis | Zendy

Fang Bai | Zendy; Yunshu Lu | Zendy; Kejin Wu | Zendy; Qing Chen | Zendy; Longlong Ding | Zendy; Meixin Ge | Zendy; Ziyi Weng | Zendy

Open Access

Protecting Effects of Gonadotropin-Releasing Hormone Agonist on Chemotherapy-Induced Ovarian Damage in Premenopausal Breast Cancer Patients: A Systematic Review and Meta-Analysis

Author(s) -

Fang Bai,

Yunshu Lu,

Kejin Wu,

Qing Chen,

Longlong Ding,

Meixin Ge,

Ziyi Weng

Publication year - 2017

Publication title -

breast care

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.767

H-Index - 30

eISSN - 1661-3805

pISSN - 1661-3791

DOI - 10.1159/000454983

Subject(s) - medicine , publication bias , meta analysis , oncology , breast cancer , agonist , odds ratio , cochrane library , confidence interval , funnel plot , gonadotropin releasing hormone agonist , chemotherapy , gonadotropin releasing hormone , gynecology , hormone , cancer , buserelin , receptor , luteinizing hormone

There is no universal consensus on whether gonadotropin-releasing hormone (GnRH) agonist could protect chemotherapy-induced ovarian damage in premenopausal breast cancer patients. This meta-analysis was conducted to estimate the protective effects of GnRH agonist on premenopausal breast cancer patients in details.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research